Company: CF
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001324404-25-000030
Chunk: 127

Company: CF Industries Holdings, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 127
---
urchase program. Diluted weighted-average common shares outstanding were 161.2 million shares for the three months ended September 30, 2025, a decrease of 10% compared to diluted weighted-average common shares outstanding of 178.6 million shares for the three months ended September 30, 2024.

27

Table of ContentsCF INDUSTRIES HOLDINGS, INC. 

Items Affecting Comparability of Results

For the three months ended September 30, 2025 and 2024, we reported net earnings attributable to common stockholders of $353 million and $276 million, respectively. For the nine months ended September 30, 2025 and 2024, we reported net earnings attributable to common stockholders of $1.05 billion and $890 million, respectively. In addition to the impact of market conditions and current developments, including the 45Q tax credit income, discussed above, certain items affected the comparability of our financial results for the three and nine months ended September 30, 2025 and 2024. The following table and related discussion outline these items and their impact on the comparability of our financial results for these periods. The descriptions of items below that refer to amounts in the table refer to the pre-tax amounts unless otherwise noted. 

Three Months Ended September 30,Nine Months Ended September 30,2025202420252024Pre-TaxAfter-TaxPre-TaxAfter-TaxPre-TaxAfter-TaxPre-TaxAfter-Tax(in millions)Unrealized net mark-to-market (gain) loss on natural gas derivatives(1)$(1)$(1)$1 $1 $1 $— $(33)$(25)(Gain) loss on foreign currency transactions(2)(3)(4)(3)1 1 (5)(5)2 2 Blue Point joint venture construction costs(2)(3)2 1 — — 4 3 — — Loss on sale of Ince facility(4)— — — — 23 21 — — Integration costs— — — — — — 4 3 Canada Revenue Agency Competent Authority Matter:Interest expense (income)—net(5)— — (40)(39)— — (40)(39)

______________________________________________________________________________

(1)Included in cost of sales in our consolidated statements of operations.

(2)Included in other operating